The recent signing into law by President Barack Obama of the 21st Century Cures Act, a bipartisan bill whose aims include…
Articles by Margarida Azevedo, MSc
Scientists have created a risk profile that uses three genetic markers to determine whether there is a high or low…
Results from the Phase 2 SUSTAIN clinical trial demonstrated that crizanlizumab (SEG101, Selexys Pharmaceuticals, Novartis), an anti-P-selectin antibody,…
Imara recently presented positive preclinical results of its lead drug candidate IMR-687, a potent PDE9 inhibitor for the treatment…
The UT Physicians Comprehensive Sickle Cell Center has expanded its facilities in response to the needs of an increasing…
Karolinska Development’s Modus Therapeutics has been issued two U.S. patents covering its proprietary drug sevuparin, a candidate for the…
Imara is scheduled to present preclinical efficacy and safety data on IMR-687, its lead product candidate for the treatment of…
The U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) from Emmaus…
The U.S. Food and Drug Administration (FDA) has approved the use of Immucor’s PreciseType HEA test to screen…
Treatment outcomes for people with sickle cell disease (SCD) have improved significantly in the past few decades. Today, over…